ConvaTec Group PLC (LON:CTEC) had its target price upped by Peel Hunt from GBX 380 ($4.93) to GBX 390 ($5.06) in a research report report published on Wednesday, August 9th, StockTargetPrices.com reports. They currently have a buy rating on the stock.
Several other equities research analysts have also issued reports on CTEC. Numis Securities Ltd lowered their price objective on ConvaTec Group PLC from GBX 260 ($3.38) to GBX 250 ($3.25) and set a reduce rating for the company in a research note on Wednesday, August 9th. Deutsche Bank AG reiterated a buy rating and issued a GBX 330 ($4.28) price target on shares of ConvaTec Group PLC in a report on Sunday, August 6th. J P Morgan Chase & Co reduced their price target on ConvaTec Group PLC from GBX 318 ($4.13) to GBX 303 ($3.93) and set an overweight rating on the stock in a report on Friday, August 4th. Goldman Sachs Group, Inc. (The) reiterated a buy rating and issued a GBX 340 ($4.41) price target on shares of ConvaTec Group PLC in a report on Thursday, August 3rd. Finally, Credit Suisse Group increased their price target on ConvaTec Group PLC from GBX 275 ($3.57) to GBX 290 ($3.76) and gave the stock a neutral rating in a report on Friday, May 5th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the company’s stock. The company currently has a consensus rating of Buy and an average target price of GBX 312.33 ($4.05).
ConvaTec Group PLC (CTEC) opened at 286.30 on Wednesday. The stock’s 50 day moving average price is GBX 302.07 and its 200 day moving average price is GBX 288.40. The stock’s market capitalization is GBX 5.59 billion. ConvaTec Group PLC has a 1-year low of GBX 213.00 and a 1-year high of GBX 349.10.
The company also recently disclosed a dividend, which will be paid on Friday, October 20th. Shareholders of record on Thursday, September 7th will be issued a dividend of GBX 1.06 ($0.01) per share. The ex-dividend date is Thursday, September 7th. This represents a yield of 0.36%.
About ConvaTec Group PLC
ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.
What are top analysts saying about ConvaTec Group PLC? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for ConvaTec Group PLC and related companies.